NCT00244192View on ClinicalTrials.gov

Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

December 31, 2005

Conditions
COPDCachexia
Interventions
DRUG

infliximab (Remicade)

Trial Locations (1)

6085 NM

Center for Integrated Rehabilitation and Organ failure (CIRO) Horn, Horn

Sponsors

Collaborators (1)

Centocor, Inc.
All Listed Sponsors
collaborator

Centocor, Inc.

INDUSTRY

lead

Center for Integrated Rehabilitation and Organ Failure Horn

OTHER